Department of Ultrasound, Peking University Third Hospital, Beijing 100191, China.
Department of Biomedical Engineering, College of Future Technology, National Biomedical Imaging Center, Peking University, Beijing 100871, China.
ACS Nano. 2021 Dec 28;15(12):20164-20180. doi: 10.1021/acsnano.1c08108. Epub 2021 Dec 13.
Nanomaterials that combine multimodality imaging and therapeutic functions within a single nanoplatform have drawn extensive attention for molecular medicines and biological applications. Herein, we report a theranostic nanoplatform based on a relatively smaller (<20 nm) iron oxide loaded porphyrin-grafted lipid nanoparticles (FeO@PGL NPs). The amphiphilic PGL easily self-assembled on the hydrophobic exterior surface of ultrasmall FeO NPs, resulting in a final ultrasmall FeO@PGL NPs with diameter of ∼10 nm. The excellent self-assembling nature of the as-synthesized PGL NPs facilitated a higher loading of porphyrins, showed a negligible dark toxicity, and demonstrated an excellent photodynamic effect against HT-29 cancer cells . The experimental results further confirmed that FeO@PGL NPs were ideally qualified for both the fluorescence and magnetic resonance (MR) imaging guided nanoplatforms to track the biodistribution and therapeutic responses of NPs as well as to simultaneously trigger the generation of highly cytotoxic reactive oxygen species (ROS) necessary for excellent photodynamic therapy (PDT). After recording convincing therapeutic responses, we further evaluated the ability of FeO@PGL NPs/FeO@Lipid NPs for ferroptosis therapy (FT) via tumor microenvironment (TME) modulation for improved anticancer activity. We hypothesized that tumor-associated macrophages (TAMs) could significantly improve the efficacy of FT by accelerating the Fenton reaction . In our results, the Fe ions released directly contributed to the Fenton reaction, whereas the presence of RAW 264.7 macrophages further accelerated the ROS generation as observed by the fluorescence imaging. The significant increase in the ROS during the coincubation of NPs, endocytosed by HT-29 cells and RAW264.7 cells, further induced increased cellular toxicity of cancer cells.
将具有多种模态成像和治疗功能的纳米材料集成在单个纳米平台中,已引起人们对分子医学和生物应用的广泛关注。在此,我们报告了一种基于相对较小(<20nm)载氧化铁卟啉接枝脂质纳米粒子(FeO@PGL NPs)的治疗诊断纳米平台。两亲性 PGL 很容易在超小 FeO NPs 的疏水性外表面自组装,最终得到直径约为 10nm 的超小 FeO@PGL NPs。所合成的 PGL NPs 的出色自组装性质促进了卟啉的高负载,表现出可忽略的暗毒性,并对 HT-29 癌细胞显示出优异的光动力效应。实验结果进一步证实,FeO@PGL NPs 是理想的荧光和磁共振(MR)成像引导纳米平台,可用于跟踪 NPs 的生物分布和治疗反应,同时触发生成高度细胞毒性的活性氧(ROS),这对于优异的光动力治疗(PDT)是必要的。在记录令人信服的治疗反应后,我们通过肿瘤微环境(TME)调节进一步评估了 FeO@PGL NPs/FeO@Lipid NPs 用于铁死亡治疗(FT)的能力,以提高抗癌活性。我们假设肿瘤相关巨噬细胞(TAMs)通过加速芬顿反应,可显著提高 FT 的疗效。在我们的结果中,释放的 Fe 离子直接有助于芬顿反应,而 RAW 264.7 巨噬细胞的存在进一步加速了 ROS 的产生,这可以通过荧光成像观察到。在 NPs 共孵育期间,ROS 的显著增加,被 HT-29 细胞和 RAW264.7 细胞内吞,进一步导致癌细胞的细胞毒性增加。